ABL Bio Inc. (KOSDAQ: 298380)
South Korea
· Delayed Price · Currency is KRW
40,500
+5,400 (15.38%)
Oct 11, 2024, 9:00 AM KST
ABL Bio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Oct '24 Oct 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,945,935 | 1,178,156 | 1,099,129 | 1,041,424 |
| Market Cap Growth | 16.21% | 7.19% | 5.54% | - |
| Enterprise Value | 1,954,896 | 1,126,398 | 1,038,936 | - |
| Last Close Price | 40500.00 | 24600.00 | 23000.00 | 22100.00 |
| PE Ratio | - | -444.70 | 340.96 | -23.83 |
| PS Ratio | 58.87 | 17.97 | 16.33 | 195.31 |
| PB Ratio | 36.61 | 15.90 | 15.81 | 18.61 |
| P/FCF Ratio | -14.71 | -34.55 | 15.68 | -24.88 |
| P/OCF Ratio | -16.66 | -41.54 | 15.24 | -25.65 |
| EV/Sales Ratio | 59.32 | 17.18 | 15.44 | - |
| EV/EBITDA Ratio | -27.89 | -41225.65 | 321.37 | - |
| EV/EBIT Ratio | -26.17 | -430.40 | 1144.20 | - |
| EV/FCF Ratio | -26.60 | -33.03 | 14.83 | - |
| Debt / Equity Ratio | 0.82 | 0.59 | 0.60 | 0.01 |
| Debt / EBITDA Ratio | - | - | 12.94 | - |
| Debt / FCF Ratio | -0.59 | -1.29 | 0.60 | -0.01 |
| Asset Turnover | 0.21 | 0.38 | 0.54 | - |
| Quick Ratio | 1.48 | 1.71 | 1.09 | 5.01 |
| Current Ratio | 1.55 | 1.81 | 1.12 | 5.20 |
| Return on Equity (ROE) | -56.84% | -3.69% | 5.11% | - |
| Return on Assets (ROA) | -16.60% | -0.95% | 0.45% | - |
| Return on Capital (ROIC) | -22.70% | -1.43% | 0.68% | - |
| Earnings Yield | -2.06% | -0.22% | 0.29% | -4.18% |
| FCF Yield | -3.78% | -2.89% | 6.38% | -4.02% |
| Buyback Yield / Dilution | -0.29% | -0.58% | -1.27% | - |
| Total Shareholder Return | -0.29% | -0.58% | -1.27% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.